Variations in the medical treatment of inflammatory bowel disease among gastroenterologists

Gastroenterology Report
Shailendra SinghKofi Clarke

Abstract

With expanding available treatment options and evolving understanding of the risks and benefits of medical therapies for inflammatory bowel disease (IBD), there is the possibility of significant variations in treatment and outcomes. Little is known about the variation in treatment between IBD specialists and other gastroenterology (GI) physicians. Evaluating possible variations is an important first step to help address standardized care and optimize treatment. We studied the differences in use of biologics and immunomodulators in the management of IBD patients at a tertiary care hospital between IBD-trained physicians and other gastroenterologists. A total of 325 IBD patients were included in the analysis. Of these, 216 patients received care with an IBD physician and 109 had other GI/non-IBD physicians as their main caregivers. The unadjusted use of immunomodulators (35.6% vs 16.5%, p = 0.001), biologics (45.8% vs 22.9%, p =0.001) and dual therapy (biologics and immunomodulator) (14.4% vs 3.7%, p =0.001) was significantly higher in the IBD-physician group. These differences in therapy between the two groups remained after adjusting for patient and disease characteristics. There are significant variations in the treatment of p...Continue Reading

References

Feb 9, 2007·Inflammatory Bowel Diseases·Michael D KappelmanJonathan A Finkelstein
Jan 29, 2009·The American Journal of Gastroenterology·Gary R LichtensteinUNKNOWN Practice Parameters Committee of American College of Gastroenterology
Jan 14, 2010·The American Journal of Gastroenterology·Asher KornbluthUNKNOWN Practice Parameters Committee of the American College of Gastroenterology
Apr 6, 2011·Gut·Craig MowatUNKNOWN IBD Section of the British Society of Gastroenterology
Jul 31, 2012·Gut·Markus F Neurath, Simon P L Travis
Sep 29, 2012·Journal of Crohn's & Colitis·Eric I BenchimolMichael D Kappelman
Jan 1, 2014·Health Policy·John E Wennberg
Dec 3, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ashwin N AnanthakrishnanRobert S Sandler
Feb 2, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Sunanda Kane

❮ Previous
Next ❯

Citations

Jan 24, 2019·Journal of Gastroenterology and Hepatology·Minkyung HanSohee Park
Apr 14, 2020·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Sharmila S PrasadTherése Kairuz
Aug 15, 2021·Journal of Crohn's & Colitis·Bénédicte CaronLaurent Peyrin-Biroulet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Related Papers

Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology
Mohammad BilalKofi Clarke
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Shomron Ben-HorinEuropean Crohn's and Colitis Organization (ECCO)
© 2022 Meta ULC. All rights reserved